Edesa Biotech (EDSA) Receivables (2013 - 2026)
Edesa Biotech (EDSA) reported Receivables of $228,051 for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 20.5% from $286,743 a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Receivables (2013 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Edesa Biotech posted Receivables of $642,866, up 137.3% from FY2024.
- Receivables has a five-year compound annual growth rate of 49.0% (FY2020 to FY2025).
- By fiscal year, Receivables came in at $270,908 in FY2024 (-56.8%), $626,543 in FY2023 (-73.4%), $2.36 million in FY2022 (-62.8%) and $6.33 million in FY2021.
- The fiscal Q3 2026 figure ranks as the lowest quarterly Receivables since fiscal Q3 2023.
- Year over year, Receivables gained in two of the last seven quarters, with an average decline of 11.9%.
- The high point for year-over-year Receivables in five years was fiscal Q1 2024 (growth of 492.6%); the low point was fiscal Q3 2023 (a decline of 98.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Edesa Biotech | 26.08 Mn | -19.46 Mn | - | 228,051.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 228,051.00 |
| Dec 31, 2025 | 431,325.00 |
| Sep 30, 2025 | 642,866.00 |
| Jun 30, 2025 | 286,743.00 |
| Mar 31, 2025 | 382,440.00 |
| Dec 31, 2024 | 350,639.00 |
| Sep 30, 2024 | 270,908.00 |
| Jun 30, 2024 | 551,064.00 |
| Mar 31, 2024 | 1.11 Mn |
| Dec 31, 2023 | 743,569.00 |
| Sep 30, 2023 | 626,543.00 |
| Jun 30, 2023 | 42,866.00 |
| Mar 31, 2023 | 50,233.00 |
| Dec 31, 2022 | 125,477.00 |
| Sep 30, 2022 | 2.36 Mn |
| Jun 30, 2022 | 2.50 Mn |
| Mar 31, 2022 | 2.35 Mn |
| Dec 31, 2021 | 5.51 Mn |
| Sep 30, 2021 | 6.33 Mn |
| Jun 30, 2021 | 8.18 Mn |
API Access
Edesa Biotech Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();